(Q30982315)

28 June 2017

Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia (English)

1 reference

28 June 2017

1 reference

L Pagana

1

1 reference

28 June 2017

A Pulsoni

2

1 reference

28 June 2017

M E Tosti

3

1 reference

28 June 2017

G Avvisati

4

1 reference

28 June 2017

L Mele

5

1 reference

28 June 2017

M Mele

6

1 reference

28 June 2017

B Martino

7

1 reference

28 June 2017

G Visani

8

1 reference

28 June 2017

R Cerri

9

1 reference

28 June 2017

E Di Bona

10

1 reference

28 June 2017

R Invernizzi

11

1 reference

28 June 2017

A Nosari

12

1 reference

28 June 2017

M Clavio

13

1 reference

28 June 2017

B Allione

14

1 reference

28 June 2017

P Coser

15

1 reference

28 June 2017

A Candoni

16

1 reference

28 June 2017

A Levis

17

1 reference

28 June 2017

A Camera

18

1 reference

28 June 2017

L Melillo

19

1 reference

28 June 2017

G Leone

20

1 reference

28 June 2017

F Mandelli

21

1 reference

28 June 2017

Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

22

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

British Journal of Haematology

28 June 2017

1 reference

28 June 2017

112

1 reference

28 June 2017

1

1 reference

28 June 2017

109-117

1 reference

Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease

28 June 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Second cancers and other late side effects of cancer treatment. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Association of the Philadelphia chromosome and 5q- in secondary blood disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Leukemia following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Leukemia following chemotherapy for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Second neoplasms after acute lymphoblastic leukemia in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

The secondary leukemias: challenges and research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Therapy-related myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02527.X

10.1046/J.1365-2141.2001.02527.X

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference